Envista (NYSE:NVST – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.01, Zacks reports. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. Envista updated its FY 2025 guidance to 0.950-1.050 EPS.
Envista Price Performance
Shares of Envista stock traded up $0.45 on Wednesday, reaching $20.58. 4,921,988 shares of the stock were exchanged, compared to its average volume of 2,076,956. The firm’s 50 day moving average is $20.00 and its 200-day moving average is $19.09. The firm has a market cap of $3.54 billion, a PE ratio of -2.65, a P/E/G ratio of 1.82 and a beta of 1.34. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.08. Envista has a one year low of $15.15 and a one year high of $24.79.
Analysts Set New Price Targets
A number of analysts have recently issued reports on NVST shares. Jefferies Financial Group raised their target price on shares of Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Stifel Nicolaus boosted their price objective on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research report on Thursday, October 31st. Piper Sandler lifted their price target on Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Monday. Finally, Leerink Partnrs raised Envista from a “strong sell” rating to a “hold” rating in a report on Thursday, October 31st. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $20.21.
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
See Also
- Five stocks we like better than Envista
- The Basics of Support and Resistance
- 3 Must-Have ETFs Set to Dominate This Quarter
- Ride Out The Recession With These Dividend KingsĀ
- Seeking Stability? These 3 Stocks Offer Strong Potential
- How to Profit From Growth Investing
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.